FASEB Releases Its Newest Publication In The Horizons In Bioscience Series

April 30, 2014
Bethesda, MD – The Federation of American Societies for Experimental Biology (FASEB) is pleased to announce the release of the latest publication in the Horizons in Bioscience series, “Epigenetics: Looking Beyond Our DNA.” This article describes the emerging field of epigenetics and its contributions toward treating and preventing disease.

Our physical appearance and susceptibility to disease were once thought to be hard-wired within our DNA, but now scientists are starting to decipher how biological and environmental factors influence health and disease. Epigenetics is a rapidly advancing area of investigation in which changes in gene expression as a result of DNA modifications rather than from changes in the underlying DNA sequence are studied. With support from the National Institutes of Health and other federal agencies, the study of epigenetics has led to the development of therapies for cancer and to a better understanding of disease susceptibility.

The Horizons in Bioscience series is a collection of short, illustrated articles, published by FASEB, that describe scientific discoveries on the brink of clinical application. Hardcopies of the articles are available at no cost for educational or advocacy purposes and can be requested by visiting the Breakthroughs in Bioscience website at www.faseb.org/breakthroughs or by contacting FASEB’s Office of Public Affairs at 301-634-7650.

Categories: Science Policy & Advocacy; FASEB General Announcements;